HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III.

Abstract
Nineteen patients with types I and III Ehlers-Danlos syndrome were hospitalized at our institution between 1973 and 1978. Chest roentgenogram, electrocardiogram, and echocardiogram were done; 11 patients underwent cardiac catheterization. Thirty-five cardiac or great vessel abnormalities were detected. Fifteen patients had nitral valve prolapse; six also had tricuspid valve prolapse. Dilatation of the aortic root or extasia of the sinuses of Valsalva, or both, occurred in six patients. Dilatation of the pulmonary artery and annulus caused pulmonary regurgitation in one patient. Congenital heart defects included bicuspid aortic valve (two), pulmonary valvular stenosis (one), ventricular septal defect (two), and an atrial septal defect (one). The apparent high prevalence of cardiovascular abnormalities in hospitalized patients with types I and III Ehlers-Danlos syndrome necessitates a careful cardiovascular evaluation. Conversely, Ehlers-Danlos syndrome types I and III should be excluded in patients with mitral or tricuspid valve prolapse, great vessel dilatation, and congenital heart defects.
AuthorsC V Leier, T D Call, P K Fulkerson, C F Wooley
JournalAnnals of internal medicine (Ann Intern Med) Vol. 92 Issue 2 Pt 1 Pg. 171-8 (Feb 1980) ISSN: 0003-4819 [Print] United States
PMID7352721 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adolescent
  • Adult
  • Cardiac Catheterization
  • Child
  • Echocardiography
  • Ehlers-Danlos Syndrome (complications)
  • Electrocardiography
  • Female
  • Heart (diagnostic imaging)
  • Heart Defects, Congenital (complications, diagnosis)
  • Heart Diseases (complications)
  • Humans
  • Male
  • Middle Aged
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: